Abdi Ibrahim Pharmaceuticals, the leader in the Turkish pharmaceutical industry for 21 years, continues its unwavering commitment to investing in biotechnology. Abdi İbrahim has announced a technology transfer agreement with the Spanish biosimilar developer, which is among the world’s leading…
The University of Tsukuba and Astellas Pharma announced that they have signed a letter of confirmation regarding a strategic partnership to accelerate the digitalization of the drug discovery research field, as well as the development of the life science ecosystem…
Novo Nordisk announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within serious chronic diseases. The investment comes as Novo Nordisk…
Biogen today announced the appointment of Monish Patolawala, currently President and CFO of 3M, to the Company’s Board of Directors, effective January 1, 2024. As an accomplished financial executive, Mr. Patolawala is qualified as an Audit Committee financial expert and…
AstraZeneca announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development of next generation therapeutics in areas of high unmet need, including oncology, immunology and rare diseases. Under the terms of the collaboration agreement,…
Bristol Myers Squibb announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board…
Boehringer Ingelheim now presents itself with a new corporate branding that is designed to inspire deeper connection with the company’s diverse customers, partners, and employees. The evolved brand includes several striking changes including the introduction of a standout color palette…
Erasmus MC staff are teaming up with researchers from EUR and TU Delft to work on sustainable care. Within three research programmes, they are committed to sustainable operating rooms, endoscopy and innovation for nurses. The new sustainable programmes are SMART…
It started with one magical model, no dedicated space and a few staff who saw the transformative power of molded plastics, printed layer by layer into a physical, life-size anatomical representation. This 3D-printed replica of conjoined twins was the big…
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the successful close of Sofinnova Digital Medicine I at $200 million (€190M), significantly exceeding its target. The fund, spearheaded by Partners Edward Kliphuis…